SuperworthInsmed shares outstanding INSM
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 217.4M
- On a year earlier
- +14.8%
- more shares
Insmed had 217.4M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 14.8% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 213.6M | +19% |
| FY2024 | 179M | +24% |
| FY2023 | 144.8M | +9% |
| FY2022 | 132.7M | +12% |
| FY2021 | 118.5M | +16% |
| FY2020 | 102.3M | +14% |
| FY2019 | 89.5M | +16% |
| FY2018 | 77.1M | +1% |
| FY2017 | 76.6M | +24% |
| FY2016 | 62M | +0% |
| FY2015 | 61.8M | +24% |
| FY2014 | 49.7M | +27% |
| FY2013 | 39.1M | +25% |
| FY2012 | 31.4M | +26% |
| FY2011 | 24.8M | +78% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 217.4M | +15% | |
| Q1 FY26 | 215.5M | +19% | |
| Q4 FY25 | 213.6M | +19% | |
| Q3 FY25 | 211.8M | +22% | |
| Q2 FY25 | 189.3M | +22% | |
| Q1 FY25 | 180.9M | +22% | |
| Q4 FY24 | 179M | +24% | |
| Q3 FY24 | 173.7M | +22% | |
| Q2 FY24 | 154.7M | +12% | |
| Q1 FY24 | 148.5M | +9% | |
| Q4 FY23 | 144.8M | +9% | |
| Q3 FY23 | 142.9M | +18% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Insmed
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.